| 000 | 01767 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517042007.0 | ||
| 264 | 0 | _c20160121 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a1462-0332 | ||
| 024 | 7 |
_a10.1093/rheumatology/kev243 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGajic-Veljic, Mirjana | |
| 245 | 0 | 0 |
_aImportance of low serum DNase I activity and polyspecific anti-neutrophil cytoplasmic antibodies in propylthiouracil-induced lupus-like syndrome. _h[electronic resource] |
| 260 |
_bRheumatology (Oxford, England) _cNov 2015 |
||
| 300 |
_a2061-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Antineutrophil Cytoplasmic _xblood |
| 650 | 0 | 4 |
_aAntithyroid Agents _xadverse effects |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aDeoxyribonucleases _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperthyroidism _xdrug therapy |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aPropylthiouracil _xadverse effects |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSyndrome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBonaci-Nikolic, Branka | |
| 700 | 1 | _aLekic, Branislav | |
| 700 | 1 | _aSkiljevic, Dusan | |
| 700 | 1 | _aCiric, Jasmina | |
| 700 | 1 | _aZoric, Svetlana | |
| 700 | 1 | _aStojimirovic, Biljana | |
| 700 | 1 | _aNikolic, Milos | |
| 773 | 0 |
_tRheumatology (Oxford, England) _gvol. 54 _gno. 11 _gp. 2061-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/rheumatology/kev243 _zAvailable from publisher's website |
| 999 |
_c25063629 _d25063629 |
||